Who
Kapila K. Anand
Director
Company insider
Files Form 4 as: Director, Elanco Animal Health; Director, Omega Healthcare Investors; Director, ESH Hospitality; Director, Extended Stay America.
In numbers
- Trades disclosed
- 69
- Buys
- 6
- Sells
- 1
- Bought
- $142K
- Sold
- $797K
- Companies
- 4
- Companies where not an officer
- 4
- First trade
- 4 Aug 2016
- Last trade
- 30 Sep 2026
- Last filed
- 1 Oct 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 30 Sep 2026filed 1 Oct 2026 | ELAN Elanco Animal Healthoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | $14K642.028 at $22.39 | filing |
| 30 Jun 2026filed 2 Jul 2026 | ELAN Elanco Animal Healthoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | $14K584.112 at $24.61 | filing |
| 30 Jun 2026filed 2 Jul 2026 | ELAN Elanco Animal Healthoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | $14K584.11 at $24.61 | filing |
| 5 Jun 2026filed 9 Jun 2026 | OHI Omega Healthcare Investorsoption or derivative · REITs | SEC FORM 4 Code A | —6,205 at $0.00 | filing |
| 5 Jun 2026filed 9 Jun 2026 | OHI Omega Healthcare Investorsoption or derivative · REITs | SEC FORM 4 Code A | —6,205 at $0.00 | filing |
| 21 May 2026filed 26 May 2026 | ELAN Elanco Animal HealthPharmaceuticals | SEC FORM 4 Code A | —4,678 at $0.00 | filing |
| 21 May 2026filed 26 May 2026 | ELAN Elanco Animal HealthPharmaceuticals | SEC FORM 4 Code A | —12,196 at $0.00 | filing |
| 21 May 2026filed 26 May 2026 | ELAN Elanco Animal HealthPharmaceuticals | SEC FORM 4 Code A | —4,678 at $0.00 | filing |
| 21 May 2026filed 26 May 2026 | ELAN Elanco Animal HealthPharmaceuticals | SEC FORM 4 Code A | —12,196 at $0.00 | filing |
| 31 Mar 2026filed 2 Apr 2026 | ELAN Elanco Animal Healthoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | $14K600.71 at $23.93 | filing |
| 31 Mar 2026filed 2 Apr 2026 | ELAN Elanco Animal Healthoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | $14K600.71 at $23.93 | filing |
| 31 Dec 2025filed 5 Jan 2026 | ELAN Elanco Animal Healthoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | $8,625381.131 at $22.63 | filing |
| 31 Dec 2025filed 5 Jan 2026 | ELAN Elanco Animal Healthoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | $8,625381.13 at $22.63 | filing |
| 28 Nov 2025filed 2 Dec 2025 | ELAN Elanco Animal HealthPharmaceuticals | SEC FORM 4 Code A | —10,314 at $0.00 | filing |
| 30 Sep 2025filed 2 Oct 2025 | ELAN Elanco Animal Healthoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | $8,625428.25 at $20.14 | filing |
| 30 Jun 2025filed 2 Jul 2025 | ELAN Elanco Animal Healthoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | $8,625603.99 at $14.28 | filing |
| 6 Jun 2025filed 10 Jun 2025 | OHI Omega Healthcare Investorsoption or derivative · REITs | SEC FORM 4 Code A | —6,150 at $0.00 | filing |
| 31 Mar 2025filed 2 Apr 2025 | ELAN Elanco Animal Healthoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | $8,625821.43 at $10.50 | filing |
| 29 Nov 2024filed 3 Dec 2024 | ELAN Elanco Animal HealthPharmaceuticals | SEC FORM 4 Code A | —18,169 at $0.00 | filing |
| 7 Jun 2024filed 11 Jun 2024 | OHI Omega Healthcare Investorsoption or derivative · REITs | SEC FORM 4 Code A | —5,756 at $0.00 | filing |
News
Omega Healthcare Investors (NYSE:OHI) Given New $52.00 Price Target at UBS GroupOHI · dailypolitical.com · 13 Oct 2026Omega Healthcare Investors, Inc. (NYSE:OHI) Stock Has Consensus Target Price of $49.71OHI · dailypolitical.com · 13 Oct 2026
0 headlines in the last 90 days name Kapila K. Anand; 2 articles from the last 14 days about the 2 companies they traded most, at most three about any one of them.